<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04906889</url>
  </required_header>
  <id_info>
    <org_study_id>dexmedetomidine-lidocaine</org_study_id>
    <nct_id>NCT04906889</nct_id>
  </id_info>
  <brief_title>the Effect of Dexmedetomidine and Licodaine on Acute Postoperative Pain in Gynecological Laparoscopy</brief_title>
  <official_title>The Effect of Opioid-free Anesthesia Using Dexmedetomidine-lidocaine on Acute Postoperative Pain in Gynecological Laparoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Catholic University of Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Catholic University of Korea</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the effect of opioid-free anesthesia using&#xD;
      dexmedetomidine and lidocaine instead of remifentanil infusion, on the acute postoperative&#xD;
      pain after the gynecological laparoscopy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is performed to investigate the effect of dexmedetomidine and lidocaine the&#xD;
      postopeative pain, shivering, nausea and vomiting after the gynecological laparoscopy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain in recovery room</measure>
    <time_frame>30 minuetes after the completion of surgery</time_frame>
    <description>The pain level is assessed by using NRS (numeric rating scale; 0=no pain , 10=the worst pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>shivering in recovery room</measure>
    <time_frame>30 minuetes after the completion of surgery</time_frame>
    <description>The incidence of shivering is assessed by questioning Yes or No.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative nausea and vomiting (PONV)</measure>
    <time_frame>30 minutes after the completion of surgery</time_frame>
    <description>The incidence of PONV is assessed by questioning Yes or No</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Gynecologic Disease</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine-lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The study group receives the dexmedetomidine and lidocaine infusion with general anesthesia for gynecological laparoscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>remifentanil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group receives the remifentanil infusion with general anesthesia for gynecological laparoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine Hydrochloride</intervention_name>
    <description>dexmedetomidine iv bolus for 10 minutes followed by the infusion of 0.1-1 ug/kg/h during general anesthesia</description>
    <arm_group_label>dexmedetomidine-lidocaine</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil Hydrochloride</intervention_name>
    <description>remifentanil iv infusion of 0.5-5 ng/ml (effect site concentration using TCI) during general anesthesia</description>
    <arm_group_label>remifentanil</arm_group_label>
    <other_name>remifentanil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Hydrochloride</intervention_name>
    <description>lidocaine iv bolus followed by the infusion of 1.5mg/kg/h during general anesthesia</description>
    <arm_group_label>dexmedetomidine-lidocaine</arm_group_label>
    <other_name>lidocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients scheduled for elective gynecological laparoscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  emergent surgery&#xD;
&#xD;
          -  cancer surgery&#xD;
&#xD;
          -  chronic pain requiring pain killers&#xD;
&#xD;
          -  psychiatric disease&#xD;
&#xD;
          -  preoperative bradycardia (HR &lt; 50 bpm)&#xD;
&#xD;
          -  allergies&#xD;
&#xD;
          -  pregnancy or breast feeding&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Young Eun Moon, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate professor, Department of Anesthesiology and Pain Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Young Eun Moon, MD, PhD</last_name>
    <phone>822-2258-6163</phone>
    <email>0910momo@naver.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul St.Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Seocho-gu</state>
        <zip>06591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Eun Moon, MD</last_name>
      <phone>822-2258-6163</phone>
      <email>0910momo@naver.com</email>
    </contact>
    <contact_backup>
      <last_name>Nuri Lee, MD</last_name>
      <phone>822-2258-6162</phone>
      <email>snhkry55@naver.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Seoul St.Mary's Hospital</name>
      <address>
        <city>Seocho</city>
        <zip>06591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nuri Lee, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Youngeun Moon, Md, PhD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 25, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2021</study_first_posted>
  <last_update_submitted>June 3, 2021</last_update_submitted>
  <last_update_submitted_qc>June 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Catholic University of Korea</investigator_affiliation>
    <investigator_full_name>Young Eun Moon</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

